CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 11 of 15

Annals of the Rheumatic Diseases

Briefs 401–440 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients

    Diagnostic or prognostic studyAcross diseases

  2. Ann Rheum Dis

    Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's disease

    Mechanistic studySjögren's & overlap

  3. Ann Rheum Dis

    Primary osteoarthritis chondrocyte map of chromatin conformation reveals novel candidate effector genes

    Mechanistic studyOsteoarthritis

  4. Ann Rheum Dis

    Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

    Cohort studyLupus & APS

  5. Ann Rheum Dis

    Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis

    Cohort studySpondyloarthritis & PsA

  6. Ann Rheum Dis

    Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials

    Mechanistic studyLupus & APS

  7. Ann Rheum Dis

    Validation and incorporation of digital entheses into a preliminary GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis

    Guideline or statementSpondyloarthritis & PsA

  8. Ann Rheum Dis

    Characterised intron retention profiles in muscle tissue of idiopathic inflammatory myopathy subtypes

    Mechanistic studyMyositis

  9. Ann Rheum Dis

    Disease activity drives divergent epigenetic and transcriptomic reprogramming of monocyte subpopulations in systemic lupus erythematosus

    Mechanistic studyLupus & APS

  10. Ann Rheum Dis

    Global burden of early-onset osteoarthritis, 1990–2019: results from the Global Burden of Disease Study 2019

    Secondary analysisOsteoarthritis

  11. Ann Rheum Dis

    Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Cross-sectional studyLupus & APS

  12. Ann Rheum Dis

    Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

    Cross-sectional studySpondyloarthritis & PsA

  13. Ann Rheum Dis

    Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort

    Cohort studySpondyloarthritis & PsA

  14. Ann Rheum Dis

    Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker

    Mechanistic studyGout & crystals

  15. Ann Rheum Dis

    Unveiling inflammatory and prehypertrophic cell populations as key contributors to knee cartilage degeneration in osteoarthritis using multi-omics data integration

    Mechanistic studyOsteoarthritis

  16. Ann Rheum Dis

    2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

    Guideline or statementGout & crystals

  17. Ann Rheum Dis

    Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis

    Meta-analysisSpondyloarthritis & PsA

  18. Ann Rheum Dis

    Erosive hand osteoarthritis and sarcopenia: data from Osteoarthritis Initiative cohort

    Cohort studyOsteoarthritis

  19. Ann Rheum Dis

    EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

    Guideline or statementSpondyloarthritis & PsA

  20. Ann Rheum Dis

    EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update

    Guideline or statementOsteoarthritis

  21. Ann Rheum Dis

    EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    Guideline or statementLupus & APS

  22. Ann Rheum Dis

    EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

    Guideline or statementVasculitis & PMR

  23. Ann Rheum Dis

    Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne

    Mechanistic studyAutoinflammatory & rare

  24. Ann Rheum Dis

    MRI-based synthetic CT: a new method for structural damage assessment in the spine in patients with axial spondyloarthritis – a comparison with low-dose CT and radiography

    Diagnostic or prognostic studySpondyloarthritis & PsA

  25. Ann Rheum Dis

    Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification

    Cohort studyMyositis

  26. Ann Rheum Dis

    Associations of residential greenness with bone mineral density and osteoporosis: the modifying effect of genetic susceptibility

    Cohort studyOsteoporosis

  27. Ann Rheum Dis

    Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort

    Cohort studySpondyloarthritis & PsA

  28. Ann Rheum Dis

    Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis

    Cohort studyRA

  29. Ann Rheum Dis

    Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial

    Randomized controlled trialSpondyloarthritis & PsA

  30. Ann Rheum Dis

    Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types

    Mechanistic studyAutoinflammatory & rare

  31. Ann Rheum Dis

    Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

    Guideline or statementSpondyloarthritis & PsA

  32. Ann Rheum Dis

    Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Diagnostic or prognostic studyOsteoarthritis

  33. Ann Rheum Dis

    Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis

    Mechanistic studyRA

  34. Ann Rheum Dis

    Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis

    Mechanistic studyLupus & APS

  35. Ann Rheum Dis

    Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome

    Mechanistic studyLupus & APS

  36. Ann Rheum Dis

    Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial

    Randomized controlled trialAutoinflammatory & rare

  37. Ann Rheum Dis

    CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion

    Mechanistic studySystemic sclerosis

  38. Ann Rheum Dis

    Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis

    Cross-sectional studyVasculitis & PMR

  39. Ann Rheum Dis

    Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial

    Randomized controlled trialRA

  40. Ann Rheum Dis

    Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)

    Cohort studyRA

All 596 Briefs in ExploreShowing Briefs 401–440 of 596, newest first